Bioheart-B (02185) announced interim results
- RevenueRMB14.4M
- Net profitRMB-33.2M
- Profit attributable to ownersRMB-32.7M
- Revenue YoY-31.1%
- Net profit YoY-24.3%
- Depreciation & amortisationHK$18.2M
- Capital expenditureHK$-7.6M
- Interest-bearing debtHK$12.7M
Source Bioheart-B



